As another fall conference season comes to an end and we begin to wind down after a busy few weeks, we want to thank all the educators who stopped by our booth our attended one of our hands-on workshops. We…
As another fall conference season comes to an end and we begin to wind down after a busy few weeks, we want to thank all the educators who stopped by our booth our attended one of our hands-on workshops. We…
In the news today, a team of scientists from the US, UK, and Canada have published their findings on a new and innovative technique that could lead to the development of therapeutics for a number of prevalent autoimmune diseases. Several…
Read More Identifying New Therapeutic Targets for Autoimmune Diseases
In the coming weeks, the FDA is poised to greenlight a groundbreaking medical therapy. Exa-Cel is a revolutionary gene-editing treatment that treats sickle cell disease. Learn more about the first CRISPR therapy to seek FDA approval and then bring this…
Read More In the News: Exa-Cel Gene Therapy, CRISPR, and Sickle Cell Disease
Established in 1991 by the International Diabetes Federation, November 14th is officially recognized as World Diabetes Day. The World Health Organization estimates that over 9% of adults globally suffer from diabetes, around 422 million people, and just under 4 million…